Literature DB >> 15784815

Anti-Müllerian hormone: its role in follicular growth initiation and survival and as an ovarian reserve marker.

Axel P N Themmen1.   

Abstract

In this paper the role in the ovary of anti-Müllerian hormone (AMH), a member of the transforming growth factor-beta family of growth and differentiation factors, is reviewed. AMH has an inhibitory effect on primordial follicle recruitment and may also inhibit follicle-stimulating homone-dependent selection of follicles for dominance. In addition to its functional role in the ovary, AMH in serum is an excellent candidate marker as an indication of the ovarian reserve, not only in infertility clinic patients but also in women during and after cancer treatment.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15784815     DOI： 10.1093/jncimonographs/lgi026

Source DB:  PubMed          Journal:  J Natl Cancer Inst Monogr        ISSN： 1052-6773


  21 in total

1.  Different ovarian response by age in an anti-Müllerian hormone-matched group undergoing in vitro fertilization.

Authors:  Hiroyuki Honnma; Tsuyoshi Baba; Masahiro Sasaki; Yoshiki Hashiba; Hisanori Oguri; Takanori Fukunaga; Toshiaki Endo; Yoshimasa Asada
Journal:  J Assist Reprod Genet       Date:  2011-11-16       Impact factor: 3.412

2.  Ovarian reserve tests and their utility in predicting response to controlled ovarian stimulation in rhesus monkeys.

Authors:  Julie M Wu; Diana L Takahashi; Donald K Ingram; Julie A Mattison; George Roth; Mary Ann Ottinger; Mary B Zelinski
Journal:  Am J Primatol       Date:  2010-08       Impact factor: 2.371

3.  Anti mullerian hormone: a potential marker for recruited non growing follicle of ovarian pool in women with polycystic ovarian syndrome.

Authors:  P Saikumar; Vs Kalai Selvi; K Prabhu; Prasana Venkatesh; Prashanth Krishna
Journal:  J Clin Diagn Res       Date:  2013-09-10

4.  Effect of Anti-Müllerian hormone (AMH) and bone morphogenetic protein 15 (BMP-15) on steroidogenesis in primary-cultured human luteinizing granulosa cells through Smad5 signalling.

Authors:  Ermioni Prapa; Anna Vasilaki; Konstantinos Dafopoulos; Eleni Katsiani; Panagiotis Georgoulias; Christina I Messini; George Anifandis; Ioannis E Messinis
Journal:  J Assist Reprod Genet       Date:  2015-05-24       Impact factor: 3.412

5.  Anti-Mullerian hormone normogram in an Irish subfertile population.

Authors:  M N Naasan; C Harrity; L Pentony; E Mocanu
Journal:  Ir J Med Sci       Date:  2014-02-23       Impact factor: 1.568

6.  Sustained fertility from 22 to 41 years of age in women with polycystic ovarian syndrome.

Authors:  Jan R Mellembakken; Sarah L Berga; Mirjam Kilen; Tom G Tanbo; Thomas Abyholm; Peter Fedorcsák
Journal:  Hum Reprod       Date:  2011-06-30       Impact factor: 6.918

Review 7.  Common pathophysiological mechanisms involved in luteal phase deficiency and polycystic ovary syndrome. Impact on fertility.

Authors:  Georgios Boutzios; Maria Karalaki; Evangelia Zapanti
Journal:  Endocrine       Date:  2012-08-29       Impact factor: 3.633

8.  Elevated serum anti-Müllerian hormone in adolescents with polycystic ovary syndrome: relationship to ultrasound features.

Authors:  Melissa Pawelczak; Lisa Kenigsberg; Sarah Milla; Ying-Hua Liu; Bina Shah
Journal:  J Pediatr Endocrinol Metab       Date:  2012       Impact factor: 1.634

9.  Interaction of the vitamin D receptor with a vitamin D response element in the Mullerian-inhibiting substance (MIS) promoter: regulation of MIS expression by calcitriol in prostate cancer cells.

Authors:  Peter J Malloy; Lihong Peng; Jining Wang; David Feldman
Journal:  Endocrinology       Date:  2008-12-04       Impact factor: 4.736

10.  Effects of Anesthetic Agent Propofol on Postoperative Sex Hormone Levels.

Authors:  H Kim; S-Y Ku; H C Kim; C S Suh; S H Kim; Y M Choi
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-04       Impact factor: 2.915
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.